C33H41Cl2N5O4 — CID 50991647
1-ethyl-3,3,5-trimethyl-7-[3-[2-(2-methyl-4-oxofuro[3,2-c]pyridin-5-yl)ethyl-(pyridin-4-ylmethyl)amino]propyl]-1,5-benzodiazepine-2,4-dione;dihydrochloride (PubChem CID 50991647) has the molecular formula C33H41Cl2N5O4 and a molecular weight of 642.63 g/mol. Its IUPAC name is 1-ethyl-3,3,5-trimethyl-7-[3-[2-(2-methyl-4-oxofuro[3,2-c]pyridin-5-yl)ethyl-(pyridin-4-ylmethyl)amino]propyl]-1,5-benzodiazepine-2,4-dione;dihydrochloride.
| Compound Name | 1-ethyl-3,3,5-trimethyl-7-[3-[2-(2-methyl-4-oxofuro[3,2-c]pyridin-5-yl)ethyl-(pyridin-4-ylmethyl)amino]propyl]-1,5-benzodiazepine-2,4-dione;dihydrochloride |
|---|---|
| PubChem CID | 50991647 |
| Molecular Formula | C33H41Cl2N5O4 |
| Molecular Weight | 642.63 g/mol |
| Exact Mass | 641.25 |
| IUPAC Name | 1-ethyl-3,3,5-trimethyl-7-[3-[2-(2-methyl-4-oxofuro[3,2-c]pyridin-5-yl)ethyl-(pyridin-4-ylmethyl)amino]propyl]-1,5-benzodiazepine-2,4-dione;dihydrochloride |
| SMILES | CCN1C(=O)C(C)(C)C(=O)N(C)c2cc(CCCN(CCn3ccc4oc(C)cc4c3=O)Cc3ccncc3)ccc21.Cl.Cl |
| InChI | InChI=1S/C33H39N5O4.2ClH/c1-6-38-27-10-9-24(21-28(27)35(5)31(40)33(3,4)32(38)41)8-7-16-36(22-25-11-14-34-15-12-25)18-19-37-17-13-29-26(30(37)39)20-23(2)42-29;;/h9-15,17,20-21H,6-8,16,18-19,22H2,1-5H3;2*1H |
| InChIKey | CTBHRNOKFGKHNG-UHFFFAOYSA-N |
| XLogP | 5.63 |
| TPSA | 91.89 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 44 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 642.63 |
| LogP ≤ 5 | 5.63 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'} |
|---|